Eliglustat

Eliglustat
Product Description

Eliglustat is an Endocrine-Metabolic Agent is indicated for the Long-term treatment of adult patients with Gaucher disease type 1.

Biophore's Eliglustat: Under development



Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    Price; Product Features; Product Performance; Quality Service
  • Supplied from
    India
  • Measured In
    gram; kilogram

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator

More Products from Biophore Pharma INC. (57)

  • Isotretinoin

    Product Isotretinoin

    Isotretinion is an Antiacne, and  Keratolytic agent indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.

    Biophore's Isotretinion: US DMF Filed,  Product meets USP & EP specifications,  Can be leveraged for glob...
  • Levothyroxine Sodium

    Product Levothyroxine Sodium

    Levothyroxine Sodium is indicated for the treatment of Hypothyroidism, Pituitary TSH Suppression.


    Biophore's Levothyroxine Sodium: Product meets USP & EP Specifications, Techpack Available
  • Phytonadione

    Product Phytonadione

     Phytonadione is an vitamin indicated for the treatment of  Anticoagulant-Induced Prothrombin deficiency, Prophylaxis, Hypoprothrombinemia.


    Biophore's Phytonadone:  Product meets USP , EP and JP specifications, Completely synthetic product, Impurity profile as per ICH.
    ...
  • Temozolamide

    Product Temozolamide

    Temazolamide is used in the treatment of Anticancer.

    Biophore's Temozolamide: Polymorphic form; Form III, Stringent control on genotoxic impurities, Product meets USP specificationsm, All impurities below 0.15, DMF has been reviewed and approved in Europe, Particle size requirement as per c...
  • Zileuton

    Product Zileuton

    Zileuton is an NSAID, and  Anti Asthama agent.

    Biophore's Zileuton:   USFDA approved manufacturing facility, DMF Number 26446, Completeness Assessment of the US DMF Complete.
  • Diazoxide

    Product Diazoxide

    Diazoxide is an Anti hypoglycemic agent.


  • Gadobenate dimeglumine

    Product Gadobenate dimeglumine

    Gadobenate dimeglumine is an Diagnostic Agent which is indicated for the  treatment of Magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults.


    Biophore's Gadobenate dimeglumine: API Developed, Stringent control on inorganic impurities, ...
  • Gadobutrol

    Product Gadobutrol

    Gadobutrol is an MRI Contrast Agent.

    Biophore's Gadobutrol:  Product meets the specifications of the EP draft monograph,  All impurities below 0.05, Stringent control on sodium and chloride. 
  • Liothyronine Sodium

    Product Liothyronine Sodium

    Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.

    Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed


  • Methazolamide

    Product Methazolamide

    Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
    Biophore's Methazolamide: 
  • Nadolol

    Product Nadolol

    Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.


    Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016.
  • Palbociclib

    Product Palbociclib

    Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2. 

Biophore Pharma INC. resources (1)